Search company, investor...

Founded Year



Acquired | Acquired

Total Raised




About CTRL-labs

CTRL-labs develops non-invasive neural interface technology. The technology uses electromyography (EMG) to pick up electrical signals generated by muscles in the wrists as they move. It allows users to control computers and devices with their thoughts, play video games with their minds, experience new forms of art and entertainment, and more. CTRL-labs was formerly known as Cognescent. The company was founded in 2015 and is based in New York, New York. In September 2019, CTRL-labs was acquired by Meta.

Headquarters Location

25 West 36th Street 9th Floor

New York, New York, 10018,

United States



Expert Collections containing CTRL-labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CTRL-labs is included in 1 Expert Collection, including Artificial Intelligence.


Artificial Intelligence

10,987 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

CTRL-labs Patents

CTRL-labs has filed 31 patents.

The 3 most popular patent topics include:

  • mixed reality
  • virtual reality
  • hand gestures
patents chart

Application Date

Grant Date


Related Topics




Transcription factors, Classification algorithms, Statistical classification, Cardiac arrhythmia, Machine learning


Application Date


Grant Date



Related Topics

Transcription factors, Classification algorithms, Statistical classification, Cardiac arrhythmia, Machine learning



Latest CTRL-labs News

Matrix Announces $800M Fund XII

Oct 11, 2022

Matrix, a San Francisco, CA and Boston, MA-based early-stage venture capital firm, is announcing a new $800M for Fund XII.The fund will focus on pre-seed, seed, and Series A companies across industries.Investment focus of the firm is on AI, fintech, chips and components, dev tools and infrastructure, digital health, B2B SaaS, and software defined hardware.Founded in 1977, Matrix is a venture capital firm with a team of builders who lead pre-seed through Series A rounds.Recent investments include Afterpay, Apartment List, Canva, Courier, CTRL-Labs, Fivetran, Flock Safety, GOAT, HubSpot, LogRocket, Markforged, Oculus, Side, Steadily, and Zendesk. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

CTRL-labs Frequently Asked Questions (FAQ)

  • When was CTRL-labs founded?

    CTRL-labs was founded in 2015.

  • Where is CTRL-labs's headquarters?

    CTRL-labs's headquarters is located at 25 West 36th Street, New York.

  • What is CTRL-labs's latest funding round?

    CTRL-labs's latest funding round is Acquired.

  • How much did CTRL-labs raise?

    CTRL-labs raised a total of $56M.

  • Who are the investors of CTRL-labs?

    Investors of CTRL-labs include Meta, Spark Capital, Breyer Capital, Google Ventures, Matrix Partners and 7 more.

  • Who are CTRL-labs's competitors?

    Competitors of CTRL-labs include Kernel and 7 more.


Compare CTRL-labs to Competitors

Kernel Logo

Kernel focuses on neuroscience, operating within the healthcare and technology sectors. The company's main offerings include proprietary neurotechnology used to build a portfolio of brain-based biomarkers, accelerate treatment discovery, improve patient outcomes, and transform neuro medicine. Kernel primarily serves the healthcare industry, specifically the neuro medicine sector. It was founded in 2016 and is based in Culver City, California.

Neuralink Logo

Neuralink focuses on the development of brain-computer interfaces. The company's main product is a fully implantable brain-computer interface designed to restore autonomy to individuals with unmet medical needs, such as quadriplegia, by enabling them to control computers and mobile devices with their thoughts. It primarily serves the medical technology and neuroscience sectors. It was founded in 2016 and is based in Fremont, California.

Paradromics Logo

Paradromics provides data-rate brain-computer interfaces (BCI). It aims to enable treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation and spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.

Blackrock Neurotech Logo
Blackrock Neurotech

Blackrock Neurotech is a company focused on the development of neurotechnology, specifically in the field of implantable brain-computer interfaces. The company's main offerings include devices that restore function and independence to individuals with neurological disorders, enabling them to perform tasks such as eating, drinking, sending emails, and operating robotic arms using their thoughts. Blackrock Neurotech primarily serves the healthcare and research sectors, with a particular focus on neurological disorders and paralysis. It was founded in 2008 and is based in Salt Lake City, Utah.

Neurable Logo

Neurable develops brain-computer interface (BCI) technology. It uses electroencephalogram (EEG) activity and builds an intelligent layer between the brain and computers. It focuses on building hardware and devices to measure brain activity and provide actionable insights. The company was founded in 2016 and is based in Boston, Massachusetts. .

Synchron Logo

Synchron operates as a medical device company focusing on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface that can access every corner of the brain using the blood vessels. It offers Synchron’s switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. The company was founded in 2016 and is based in Brooklyn, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.